Sirios Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-575,405
Closed -$48M 43
2016
Q2
$48M Sell
575,405
-290,633
-34% -$25.8M 2.3% 17
2016
Q1
$79.6M Buy
866,038
+209,616
+32% +$18.9M 2.99% 8
2015
Q4
$66.4M Buy
656,422
+42,111
+7% +$4.38M 2.41% 15
2015
Q3
$60.3M Buy
614,311
+266,263
+77% +$29.6M 1.98% 19
2015
Q2
$40.7M Sell
348,048
-69,226
-17% -$7.56M 1.35% 26
2015
Q1
$40.9M Sell
417,274
-627,218
-60% -$63.7M 1.51% 30
2014
Q4
$98.5M Buy
1,044,492
+543,785
+109% +$56.2M 3.58% 10
2014
Q3
$53.3M Sell
500,707
-754,263
-60% -$73.9M 1.84% 26
2014
Q2
$104M Buy
1,254,970
+56,953
+5% +$4.43M 3.56% 8
2014
Q1
$84.9M Buy
1,198,017
+663,507
+124% +$52M 2.77% 15
2013
Q4
$40.1M Buy
534,510
+305,470
+133% +$21.3M 3.11% 15
2013
Q3
$14.4M Buy
229,040
+29,500
+15% +$1.76M 1.56% 24
2013
Q2
$10.2M Buy
+199,540
New +$10.4M 1.56% 21

Other funds holding GILD

Sirios Capital Management's GILD Position: Q3 2016 in Review

Sirios Capital Management sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 575,405 shares — an estimated $48M sold.

Sirios Capital Management first reported a position in GILD in Q2 2013 and held it in 13 quarters. The position peaked at $104M in Q2 2014. 1,558 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

  • Sirios Capital Management reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
  • Sirios Capital Management sold 575,405 Gilead Sciences shares in Q3 2016, an estimated $48M.
  • Sirios Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 13 quarters.
  • Sirios Capital Management's Gilead Sciences position peaked at $104M in Q2 2014.
  • 1,558 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Sirios Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.